Grupos de protecção

Fmoc-N-Me-Asn(Trt)-OH is a peptidomimetic that mimics the sequence of the serine protease. The Fmoc group on the N-terminal amino acid is used to protect against proteolytic degradation and its methyl ester group confers stability in biological fluids. The Fmoc-N-Me-Asn(Trt)-OH has been shown to have minimal effects on endogenous protein synthesis, while also being quantified with high sensitivity and specificity. This compound has been shown to inhibit protein-protein interactions by acting as a competitive inhibitor of serine proteases.

Boc-glu(OBzl)-OH is a small-molecule drug that binds to the glutamate receptor. It has been shown to have anticancer activity in vitro and in vivo, but does not affect normal cells. Boc-glu(OBzl)-OH has been used as a synthetic substrate for the preparation of conjugates containing an amide group. This chemical can also be used as an anticancer agent by inhibiting protease activity, which inhibits cancer cell growth. The uptake of Boc-glu(OBzl)-OH can be increased by making it more acidic or by using an efficient method such as ultrasound.

Boc-D-Tyr(tBu)-OH is a natural product that is an amphipathic molecule with a cyclic structure. It has been shown to be able to inhibit the growth of bacteria, such as Staphylococcus aureus and Escherichia coli, by acting as an antibiotic. Boc-D-Tyr(tBu)-OH inhibits the synthesis of peptides by binding to the ribosome and blocking peptide elongation. This molecule also inhibits peptide synthesis by interacting with the aminoacyl site on the ribosome and preventing it from binding with amino acids. Boc-D-Tyr(tBu)-OH is synthesized in two stages: solid phase peptide synthesis and nucleophilic activation. The decapeptides are then purified and characterized based on their function.